Abstract
In April 1992, a 40-year-old TV assistant presented to his general practitioner with a two-day history of swelling of the left testicle. He had had no previous local injury or systemic symptoms apart from possible mild fever. Clinical examination revealed tenderness, swelling and increased temperature of the left gonad, but no separate mass. His family and past medical histories were unremarkable. He was on no medication.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Einhorn LH. Treatment of testicular cancer: A new and improved model, J Clin Oncol 1990; 8:1877–81.
Droz JP, Kramar A, Rey A. Prognostic factors in metastatic disease. Sem Oncol 1992; 19:181–9.
Medical Research Council Working Party on testicular tumours. Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: Results of a multicenter study. Lancet 1985; I:8–11.
Mostofi FK, Sibin LH. Histological typing of testis tumors. International classification of tumors, No. 16. Geneva, World Health Organization, 1977.
Husband J. Advances in tumour imaging. In Horwich A (ed): Testicular cancer: Investigation and management. Chapman and Hall Medical: New York 1991; 2:15–31.
Tait D, Peckham MJ, Hendry WF et al. Postchemotherapy surgery in advanced non-seminomatous germ cell tumours: The significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer 1984; 50:601–9.
Williams SD, Stablein DM, Einhorn LH et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 1987; 317:1433–8.
Donahue JP, Thornhill JA, Foster RS et al. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965-1989): Modifications of technique and impact on ejaculation. J Urol 1993; 149:137–43.
Read G, Stenning SP, Cullen MH et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. J Clin Oncol 1992; 10:1762–8.
Cullen MH on behalf of the Medical Research Council (MRC) Testicular Tumour Working Party. Short course adjuvant chemotherapy in high risk stage I non seminomatous germ cell tumours of the testis (NSGCTT): An MRC study report. Proc III Germ Cell Tumour Conference 1993; 3:47 (Abstract).
Mead GM, Stenning SP, Parkinson MC et al. The Second Medical Research council study of prognostic factors in non-seminomatous germ cell tumors. J Clin Oncol 1992; 10:85–94.
Williams SD, Birch B, Einhorn LH et al. Treatment of disseminated germ cell tumors with cisplatin, bleomycin and either vinblastine or etoposide. N Engl J Med 1987; 316:1435–40.
Einhorn LH, Williams SD, Loehrer PJ et al. Evaluation of optimal duration of chemotherapy in favourable-prognosis disseminated germ cell tumors: A Southeastern Cancer Study Group protocol. J Clin Oncol 1989; 7:387–91.
Bejorin DF, Sarosdy MF, Pfister DG et al. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multiinstitutional study. J Clin Oncol 1993; 11:598–606.
Levi JA, Raghavan D, Harvey V et al. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. J Clin Oncol 1993; 11:1300–5.
Paz-Ares L, Kaye SB. Intensive treatment schedules. Proc III Germ Cell Conference 1993; 3:56.
Einhorn LH, Williams SD, Mandelbaum I et al. Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer 1981; 48:904–10.
Paz-Ares L, Lianes P, Diaz-Puente M et al. Late relapses (LR) in malignant germ cell tumors (MCGT) treated with cisplatinbased chemotherapy. Proc Am Ass Cancer Res 1992; 34:222 (Abstract).
Toner CG, Panicek DM, Heelan RT et al. Adjuntive surgery after chemotherapy for nonseminomatous germ cell tumors: Recommendations for patient selection. J Clin Oncol 1990; 8:1683–94.
Hansen SW, Helweg-Larsen S, Trojaborg W. Long-term neurotoxicity in patients treated with cisplatin, vinblastine and bleomycin for metastatic germ cell cancer. J Clin Oncol 1989; 7:1457–61.
Hansen SW, Groth S, Daugaard G et al. Long term side-effects on renal function and blood pressure of treatment with cisplatin, vinblastine and bleomycin in patients with germ cell cancer. J Clin Oncol 1988; 6:1728–31.
Boyer M, Raghavan D. Toxicity of treatment of germ cell tumors. Sem Oncol 1992; 19:128–42.
Fossa SD, Kreuser ED, Roth GJ et al. Long-term side effects after treatment of testicular cancer. Prog Clin Biol Res 1988; 357:321–30.
von der Maase H, Rorth M, Walbom-Jorgesen S et al. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer. A study 27 cases in 500 patients. Br Med J 1986; 293:1398–401.
Pedersen-Bjergaard J, Daugaard G, Hansen ST et al. Increased risk of myelodisplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ cell tumours. Lancet 1991:338:359–63.
Rodriguez E, Mathew S, Reuter VE et al. Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors. Cancer Res 1992; 52:2285–91.
Harding MJ, Paul J, Gillis CR et al. Management of malignant teratoma: Does referral to a specialist unit matter? Lancet 1993; 341:999–1002.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Paz-Ares, L., Lianes, P., Cortes-Funes, H. (1997). The management of non-seminomatous germ cell tumours (GCT). In: Souhami, R.L. (eds) The Teaching Cases from Annals of Oncology. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5456-7_19
Download citation
DOI: https://doi.org/10.1007/978-94-011-5456-7_19
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-4117-8
Online ISBN: 978-94-011-5456-7
eBook Packages: Springer Book Archive